Merck Kgaa (MRK.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -84,500 | -33,000 | -45,000 | 186,200 | -3,700 |
| Other Working Capital | -429,600 | 170,400 | -438,600 | 520,700 | -778,000 |
| Other Operating Activity | 2,709,300 | 2,568,100 | 2,709,100 | 1,765,300 | 2,052,900 |
| Operating Cash Flow | $2,195,200 | $2,705,500 | $2,225,500 | $2,472,200 | $1,271,200 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -505,000 | -466,900 | -407,000 | -329,100 | -366,300 |
| Net Acquisitions | -13,396,300 | -1,398,400 | -15,100 | -20,600 | -161,000 |
| Purchase Of Investment | -1,740,800 | -3,143,300 | -625,600 | -725,600 | -1,076,400 |
| Sale Of Investment | 3,858,000 | 3,508,600 | N/A | 10,400 | N/A |
| Purchase Sale Intangibles | -151,700 | -141,200 | -109,600 | -144,200 | -79,700 |
| Other Investing Activity | 27,400 | 2,100 | 282,800 | 51,200 | 787,400 |
| Investing Cash Flow | $-11,935,800 | $-1,641,200 | $-874,500 | $-1,157,900 | $-896,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | -20,800 |
| Debt Issued | 10,422,800 | 1,944,900 | 193,400 | 37,500 | 16,800 |
| Debt Repayment | -2,221,300 | 0 | -750,000 | -1,000,000 | -44,100 |
| Dividend Paid | -564,200 | -505,500 | -414,400 | -102,600 | -86,800 |
| Other Financing Activity | -473,500 | -678,900 | -101,700 | -454,300 | -249,200 |
| Financing Cash Flow | $7,163,800 | $760,500 | $-1,072,700 | $-1,519,400 | $-384,100 |
| Exchange Rate Effect | 530,500 | 72,900 | -27,200 | -3,000 | 1,800 |
| Beginning Cash Position | 2,878,500 | 980,800 | 729,700 | 937,800 | 943,700 |
| End Cash Position | 832,200 | 2,878,500 | 980,800 | 729,700 | 936,600 |
| Net Cash Flow | $-2,576,800 | $1,824,800 | $278,300 | $-205,100 | $-8,900 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,195,200 | 2,705,500 | 2,225,500 | 2,472,200 | 1,271,200 |
| Capital Expenditure | -693,000 | -624,200 | -516,600 | -473,300 | -446,000 |
| Free Cash Flow | 1,502,200 | 2,081,300 | 1,708,900 | 1,998,900 | 825,200 |